The most common gastrointestinal side effects include nausea (15-44%), diarrhea (8-30%), vomiting (5-24%), and abdominal pain
This reality led me years ago to pivot toward a comprehensive risk-reduction framework that harmonizes glycemic control with weight management, lipid optimization, blood pressure regulation, smoking cessation, fitness training, sleep health, stress mitigation, and nutrition
,
Kathryn Alcarez is an experienced Primary Care Physician with 13+ years of experience and specializes in dermal fillers, wellness, and skin rejuvenation treatments
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that mimics the natural hormone GLP-1
At week 24, mean body weight reduction at the 12 mg amount was approximately 16.9%, with concentration-dependent reductions in HbA 1c across all retatrutide arms compared with placebo and dulaglutide